
Craig Rhodes appointed as Qureight Head of Partnerships
Ella Day | September 2, 2025 | Appointment | |
Qureight, a techbio company, has appointed Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organisations. The company is working to advance the understanding of lung and heart disease through its AI-powered imaging and clinical data curation platform.
Craig was formerly EMEA Director of Healthcare and Life Sciences at NVIDIA. In his new role, he will lead on securing and managing strategic relationships with pharma partner organisations, from conception through to delivery.
An experienced leader in AI across both big tech and the start-up ecosystem, Craig has over 25 years of experience driving innovation and transformation across the sector.
Craig joins Qureight from deepc, where he spearheaded strategic collaborations with the NHS to integrate AI imaging models into clinical workflows. Prior to that, Craig held roles at Intel, Oracle and also worked on clinical pathway design for the NHS at the Map of Medicine.
Muhunthan Thillai, MD, Co-founder and CEO, Qureight, said: “Welcoming Craig to the team is a key part of our ongoing mission to advance the understanding of lung and heart disease, revolutionise clinical trials and accelerate drug development through the integration of our AI-powered solutions.”
Craig commented: “I’m excited to be joining the team to support the Company’s growth and help drive its commitment to leveraging technology to improve healthcare outcomes.”






